Unpacking diabetes and the heart SPONSORED: New medicines and emerging strategies to profile risk offer more options than ever to manage CVD risk in people with diabetes.
New diabetes medication shortage will impact patient care The semaglutide shortage is having a flow on effect, with dulaglutide now also in short supply until at least the end of August.
Semaglutide shortage prompts caution around off-label prescribing GPs are being asked to prioritise the drug for people with diabetes, but with supplies critically low, what are the alternatives?
First consensus statement on T2DM in young adults released The statement contains recommendations that differ from typical management guidelines, but also fails to acknowledge the role of GPs.
Second SGLT2 inhibitor approved for heart failure Empagliflozin has been added to the PBS for symptomatic heart failure with reduced ejection fraction, regardless of diabetes status.
In Practice: Upskilling and networking opportunities A bumper edition of In Practice features new tips on named referrals, information on upcoming webinars, and much more.
Four patient groups that need GPs’ attention this Heart Week SPONSORED: The COVID-19 pandemic has made cardiovascular disease screening more critical than ever – but GPs can take practical steps to help.
Diabetes risk could be 28% higher after COVID infection A study has noted increased type 2 diabetes incidence in people recovering from COVID, signalling the need for ongoing monitoring.
Foundation grants a ‘critical support’ for GP researchers Applications for the 2022 RACGP Foundation Grants and Awards open 1 March.
New call to review gestational diabetes screening One in four pregnant women are being overdiagnosed with gestational diabetes, prompting experts to question Australia’s screening criteria.